Skip main navigation

Challenges in Developing New Vaccines: Lack of Financial Incentives

This article looks at another challenge in developing a new vaccine, lack of financial incentives. The Melioidosis vaccine is used as a a case study.
Challenges In Developing New Vaccines Lack Of Financial Incentives

As well as expense and time, another challenge of developing a vaccine is a lack of financial incentive for vaccine developers.

Neglected tropical diseases include infectious diseases that cause high rates of disability and death in low to middle income countries. Despite the global burden of disease caused by these diseases, vaccine development to date has been limited. This is because these infections occur exclusively in the world’s poorest countries where the costs of vaccine development could not be recouped from sales of vaccines.

Bacterial infections that can be treated with relatively cheap and readily available antibiotics may also not be financially attractive targets for vaccine developers. However, as antimicrobial resistance grows internationally, appetite and economic support for the development of vaccines as a means of reducing antibiotic consumption may increase.

Case study 2: Melioidosis

Melioidosis is a neglected tropical disease, and a major infectious killer in South East Asia. It particularly affects people with diabetes. Watch this video where Professor Dunachie describes research for this condition. You can also find a link to this video in the related links section at the bottom of this page, as well as a PDF summary in the downloads section.

Before a vaccine can be developed we need to understand more about how the body responds to the infection. This brings us on to the next step – biological challenges faced when designing a vaccine.

This article is from the free online

Vaccine Development: Finding a Vaccine for COVID-19 and Future Pandemics

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now